A groundbreaking melanoma study is reshaping our understanding of cancer progression across the lifespan. Researchers discovered that cancer metastasis does not follow the expected linear increase with age. Instead, melanoma spread peaked during middle age, then surprisingly declined in very elderly subjects—contradicting decades of medical assumptions.
This counterintuitive finding suggests that aging and cancer aggressiveness have a more complex relationship than previously believed. The protective effect observed in very old age may be attributed to specialized immune cells that maintain cancer dormancy. These results could fundamentally alter treatment strategies, prompting clinicians to reconsider age-based risk assessments and tailor interventions more precisely across different age groups.
Read the full article on GMJ Newsroom.
Was this article helpful?
